CAN-12

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCAN-12
Drug Alias NameCAN-12
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionProtease-activated receptor-1 antagonistsProtease-activated receptor-4 antagonists
TargetsProtease-activated receptor-4Protease-activated receptor-1
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A